MX2022012237A - Composiciones que comprenden fosfolipido y su uso. - Google Patents

Composiciones que comprenden fosfolipido y su uso.

Info

Publication number
MX2022012237A
MX2022012237A MX2022012237A MX2022012237A MX2022012237A MX 2022012237 A MX2022012237 A MX 2022012237A MX 2022012237 A MX2022012237 A MX 2022012237A MX 2022012237 A MX2022012237 A MX 2022012237A MX 2022012237 A MX2022012237 A MX 2022012237A
Authority
MX
Mexico
Prior art keywords
potential
phospholipid
composition
female subject
compositions
Prior art date
Application number
MX2022012237A
Other languages
English (en)
Inventor
Nora Schneider
Jonas Hauser
Sean Deoni
Tamas Bartfai
Zolezzi Irma Silva
Tinu Mary Samuel
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX2022012237A publication Critical patent/MX2022012237A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Abstract

La presente invención se refiere a una composición que comprende un fosfolípido, o un precursor metabólico o metabolito de este, o una mezcla de este, para usar en la promoción, apoyo u optimización de uno o más de los siguientes: (i) mielinización de novo; (ii) estructura del cerebro; (iii) conectividad del cerebro; (iv) potencial intelectual; (v) potencial cognitivo; (vi) potencial de aprendizaje; y (vii) función cognitiva en una cría de un sujeto femenino, en donde la composición es para la administración al sujeto femenino.
MX2022012237A 2016-03-30 2018-09-25 Composiciones que comprenden fosfolipido y su uso. MX2022012237A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662315163P 2016-03-30 2016-03-30
US201662315158P 2016-03-30 2016-03-30
US201662315134P 2016-03-30 2016-03-30
US201662315152P 2016-03-30 2016-03-30
US201662315142P 2016-03-30 2016-03-30
US201662328099P 2016-04-27 2016-04-27
PCT/EP2016/080787 WO2017167416A1 (en) 2016-03-30 2016-12-13 Compositions comprising phospholipid and their use

Publications (1)

Publication Number Publication Date
MX2022012237A true MX2022012237A (es) 2023-01-24

Family

ID=57777576

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2018008522A MX2018008522A (es) 2016-03-30 2016-12-13 Composiciones que comprenden fosfolipido y su uso.
MX2018011682A MX2018011682A (es) 2016-03-30 2017-03-30 Composiciones que comprenden fosfolipido y su uso.
MX2022012237A MX2022012237A (es) 2016-03-30 2018-09-25 Composiciones que comprenden fosfolipido y su uso.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2018008522A MX2018008522A (es) 2016-03-30 2016-12-13 Composiciones que comprenden fosfolipido y su uso.
MX2018011682A MX2018011682A (es) 2016-03-30 2017-03-30 Composiciones que comprenden fosfolipido y su uso.

Country Status (8)

Country Link
EP (1) EP3436027A1 (es)
CN (2) CN108367013A (es)
BR (2) BR112018011380A2 (es)
CA (2) CA3004043A1 (es)
MX (3) MX2018008522A (es)
PH (2) PH12018501028A1 (es)
SG (2) SG11201803027PA (es)
WO (2) WO2017167416A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109805390A (zh) * 2019-02-27 2019-05-28 云南大学 一种神经酸钙、神经酸锌及维生素k2复合物软胶囊
CN113508840A (zh) * 2020-04-09 2021-10-19 北京三元食品股份有限公司 乳脂球膜在制备孕妇奶粉中的应用
WO2024038010A1 (en) 2022-08-18 2024-02-22 Société des Produits Nestlé S.A. Kit to promote developmental myelination
CN117233367B (zh) * 2023-11-16 2024-02-09 哈尔滨脉图精准技术有限公司 妊娠期高血压风险评估的代谢标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE84680T1 (de) 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
US6777391B1 (en) 1999-04-29 2004-08-17 Nestec S.A. Composition for an infant formula having a low threonine content
RU2480474C2 (ru) * 2005-04-28 2013-04-27 Энзимотек Лтд. Смеси полярных липидов, их получение и применение
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2258217A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Children
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula

Also Published As

Publication number Publication date
SG11201803027PA (en) 2018-05-30
MX2018011682A (es) 2019-01-10
BR112018011380A2 (pt) 2018-12-04
EP3436027A1 (en) 2019-02-06
WO2017167416A1 (en) 2017-10-05
BR112018017350A2 (pt) 2019-01-02
CN108697718A (zh) 2018-10-23
PH12018501781A1 (en) 2019-06-17
PH12018501028A1 (en) 2019-01-28
MX2018008522A (es) 2018-08-16
CA3014832A1 (en) 2017-10-05
SG11201806434XA (en) 2018-10-30
CN108367013A (zh) 2018-08-03
WO2017167897A1 (en) 2017-10-05
CA3004043A1 (en) 2017-10-05

Similar Documents

Publication Publication Date Title
MX2022012237A (es) Composiciones que comprenden fosfolipido y su uso.
EP3984532A3 (en) Compositions comprising choline and their use
EP4292600A3 (en) Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
MX2022012236A (es) Composiciones que comprenden colina y su uso.
EP4233875A3 (en) Nutritional composition an infant formula for prmoting de novo myelination
PH12019501780A1 (en) Microbial cells, methods of producing the same, and uses thereof
BR112017008176A2 (pt) método de preparação do carbonato de ácido glicérico.
MX338158B (es) Jabon de tocador con espuma mejorada.
IN2014CN02970A (es)
MY161414A (en) Baked Confectionery
MX2022014682A (es) Composiciones y su uso.
CL2020000563A1 (es) Composición nutricional y fórmula infantil para promover la mielinización de novo. (divisional solicitud 201801603)
WO2017167898A3 (en) Compositions comprising vitamins and their use
PH12018501029A1 (en) Compositions comprising choline and their use
MX2018006293A (es) Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
MX2016013680A (es) Métodos y composiciones para el tratamiento de trastornos por el almacenamiento de lípidos.
MX353587B (es) Formulaciones farmacéuticas que contienen ipidacrina y su uso para el tratamiento de trastornos de potencia y trastornos de otras formas de actividad sexual.
MX2018001414A (es) Sal del ester metilico dihidrofenilglicina.
PL413416A1 (pl) Emulsja kosmetyczna typu olej/woda
TN2013000398A1 (en) Epoxyeicosatrienoic acid analogs and methods of making and using the same